JC viremia in natalizumab-treated patients with multiple sclerosis

N Engl J Med. 2013 Jun 6;368(23):2240-1. doi: 10.1056/NEJMc1214233.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antibodies, Viral / blood
  • DNA, Viral / blood
  • Humans
  • JC Virus / genetics
  • JC Virus / immunology
  • JC Virus / isolation & purification*
  • Leukoencephalopathy, Progressive Multifocal / etiology*
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / virology
  • Natalizumab
  • Polyomavirus Infections / diagnosis*
  • Polyomavirus Infections / etiology
  • Viremia / etiology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Viral
  • DNA, Viral
  • Natalizumab